Literature DB >> 11160404

The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.

K Ikeda1, T Kobayashi, T Ichikawa, T Kumanishi, H Niki, R Yano.   

Abstract

It is well known that there are individual differences in a sensitivity to analgesics. Several lines of evidence have suggested that the level of opioid-induced analgesia is dependent on the level of expression of the mu-opioid receptor (mu-OR). However, the molecular mechanisms underlying the diversity of the level of the opioid receptor and the opioid sensitivity among individuals remain to be elucidated. In the present study, we analyzed the opioid-receptor genes of CXBK recombinant-inbred mice, which show reduced sensitivity to opioids. Northern blotting, nucleotide sequencing, and in situ hybridization histochemical analyses demonstrated that CXBK mice possessed mu-OR mRNA with a normal coding region but an abnormally long untranslated region (UTR). In addition, the mu-OR mRNA level in CXBK mice was less than in the control mice. Next, we produced littermate mice that had inherited two copies of the wild-type mu-OR gene, had inherited two copies of the CXBK mu-OR gene, and had inherited both copies of the mu-OR genes. In these mice, inheritance of the CXBK mu-OR gene was well correlated with less mu-OR mRNA and reduced opioid effects on nociception and locomotor activity. We conclude that the CXBK mu-OR gene is responsible for the CXBK phenotypes. Because UTR differences are known to affect the level of the corresponding mRNA and protein and because UTRs are more divergent among individuals than coding regions, the present findings suggest that opioid sensitivity may vary, depending on different mu-OR levels attributable to divergent UTR of mu-OR mRNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160404      PMCID: PMC6762225     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

2.  Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia.

Authors:  I Sora; N Takahashi; M Funada; H Ujike; R S Revay; D M Donovan; L L Miner; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality.

Authors:  H H Loh; H C Liu; A Cavalli; W Yang; Y F Chen; L N Wei
Journal:  Brain Res Mol Brain Res       Date:  1998-03-01

4.  CXBK mice deficient in opiate receptors show poor electroacupuncture analgesia.

Authors:  J M Peets; B Pomeranz
Journal:  Nature       Date:  1978-06-22       Impact factor: 49.962

Review 5.  Comparison of the three mouse G-protein-activated K+ (GIRK) channels and functional couplings of the opioid receptors with the GIRK1 channel.

Authors:  K Ikeda; T Kobayashi; T Ichikawa; H Usui; S Abe; T Kumanishi
Journal:  Ann N Y Acad Sci       Date:  1996-10-31       Impact factor: 5.691

6.  Visceral chemical nociception in mice lacking mu-opioid receptors: effects of morphine, SNC80 and U-50,488.

Authors:  I Sora; X F Li; M Funada; S Kinsey; G R Uhl
Journal:  Eur J Pharmacol       Date:  1999-02-05       Impact factor: 4.432

7.  Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice.

Authors:  A S Moskowitz; R R Goodman
Journal:  Brain Res       Date:  1985-12-23       Impact factor: 3.252

8.  Identification of the gene FMR2, associated with FRAXE mental retardation.

Authors:  J Gecz; A K Gedeon; G R Sutherland; J C Mulley
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

9.  Mu opioid receptor gene variants: lack of association with alcohol dependence.

Authors:  A W Bergen; J Kokoszka; R Peterson; J C Long; M Virkkunen; M Linnoila; D Goldman
Journal:  Mol Psychiatry       Date:  1997 Oct-Nov       Impact factor: 15.992

10.  A gene for familial hemiplegic migraine maps to chromosome 19.

Authors:  A Joutel; M G Bousser; V Biousse; P Labauge; H Chabriat; A Nibbio; J Maciazek; B Meyer; M A Bach; J Weissenbach
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

View more
  11 in total

Review 1.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

Review 2.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

3.  Detection, validation, and downstream analysis of allelic variation in gene expression.

Authors:  Daniel C Ciobanu; Lu Lu; Khyobeni Mozhui; Xusheng Wang; Manjunatha Jagalur; John A Morris; William L Taylor; Klaus Dietz; Perikles Simon; Robert W Williams
Journal:  Genetics       Date:  2009-11-02       Impact factor: 4.562

4.  Opioid needs of terminally ill patients with gynecologic malignancies.

Authors:  Fumi Utsumi; Hiroaki Kajiyama; Jun Sakata; Makiko Higashi; Kaoru Niimi; Ryuichiro Sekiya; Hiroko Mitsui; Shiro Suzuki; Tomokazu Umezu; Mika Mizuno; Eiko Yamamoto; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  Int J Clin Oncol       Date:  2014-06-07       Impact factor: 3.402

5.  p38 mitogen-activated protein kinase and PI3-kinase are involved in up-regulation of mu opioid receptor transcription induced by cycloheximide.

Authors:  Do Kyung Kim; Cheol Kyu Hwang; Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

6.  Functional characterization of an endogenous Xenopus oocyte adenosine receptor.

Authors:  Toru Kobayashi; Kazutaka Ikeda; Toshiro Kumanishi
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

7.  Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-κB activation in neuronal and non-neuronal cells.

Authors:  Yadav Wagley; Cheol Kyu Hwang; Hong-Yiou Lin; Angel F Y Kam; Ping-Yee Law; Horace H Loh; Li-Na Wei
Journal:  Biochim Biophys Acta       Date:  2013-02-26

8.  Genetic correlates of morphine withdrawal in 14 inbred mouse strains.

Authors:  Pamela Metten; John C Crabbe; John K Belknap
Journal:  Drug Alcohol Depend       Date:  2008-09-06       Impact factor: 4.492

Review 9.  Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.

Authors:  Grace C Rossi; Richard J Bodnar
Journal:  Cell Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.046

10.  Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b.

Authors:  Qifang Wu; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.